Senseonics Holdings, Inc. Common Stock (SENS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Senseonics Holdings, Inc. Common Stock (SENS) has a cash flow conversion efficiency ratio of -0.202x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-15.82 Million) by net assets ($78.17 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Senseonics Holdings, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Senseonics Holdings, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Senseonics Holdings, Inc. Common Stock for a breakdown of total debt and financial obligations.
Senseonics Holdings, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Senseonics Holdings, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Horizon Oil Ltd
AU:HZN
|
0.442x |
|
PAN Group JSC
VN:PAN
|
0.370x |
|
Oxley Bridge Acquisition Limited Class A Ordinary Shares
NASDAQ:OBA
|
-0.001x |
|
Bermaz Auto Bhd
KLSE:5248
|
0.201x |
|
AK Sigorta AS
IS:AKGRT
|
0.178x |
|
Beacon Lighting Group Ltd
AU:BLX
|
0.172x |
|
MSP Steel & Power Limited
NSE:MSPL
|
0.111x |
|
M3-Brigade Acquisition V Corp. Units
NASDAQ:MBAVU
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Senseonics Holdings, Inc. Common Stock (2013–2024)
The table below shows the annual cash flow conversion efficiency of Senseonics Holdings, Inc. Common Stock from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see SENS market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-16.55 Million | $-60.47 Million | 3.652x | +286.34% |
| 2023-12-31 | $35.80 Million | $-70.16 Million | -1.960x | -107.61% |
| 2022-12-31 | $-2.58 Million | $-66.31 Million | 25.742x | +8416.86% |
| 2021-12-31 | $-185.53 Million | $-56.08 Million | 0.302x | -35.41% |
| 2020-12-31 | $-144.08 Million | $-67.42 Million | 0.468x | -97.03% |
| 2019-12-31 | $-8.65 Million | $-136.05 Million | 15.730x | +1334.89% |
| 2018-12-31 | $71.26 Million | $-90.77 Million | -1.274x | +83.39% |
| 2017-12-31 | $7.27 Million | $-55.74 Million | -7.670x | -198.40% |
| 2016-12-31 | $-4.88 Million | $-38.02 Million | 7.795x | +196.83% |
| 2015-12-31 | $-9.70 Million | $-25.46 Million | 2.626x | +207.84% |
| 2014-12-31 | $7.91 Million | $-19.27 Million | -2.435x | +99.90% |
| 2013-12-31 | $7.08K | $-17.17 Million | -2424.375x | -- |
About Senseonics Holdings, Inc. Common Stock
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabet… Read more